Hem/Onc Roundup: Lymphoma, Melanoma, Stomach Cancer, and more

Actor Jeff Bridges Reveals Lymphoma Diagnosis

Jeff Bridges, 70, has been diagnosed with lymphoma, the actor announced on Twitter Monday evening. “I have been diagnosed with Lymphoma. Although it is a serious disease, I feel fortunate that I have a great team of doctors and the prognosis is good. I’m starting treatment and will keep you posted on my recovery,” he wrote. Bridges did not share what stage his cancer is or any other specifics, including what type of lymphoma he has.

Actor Jeff Bridges Reveals Lymphoma Diagnosis—What Does This Mean?

Researchers Identify Targets to Inhibit the Spread of Melanoma

A study published in Nature Communications identified new targets to inhibit the spread of melanoma and guide treatment decisions. Researchers used melanoma cell lines and preclinical models and found that melanoma cells can initiate tumors at new sites via a powerful signaling cascade. “Rounded-amoeboid” cells, a highly invasive subset of melanoma cells located around the edge of tumors, were shown to disseminate through the body efficiently and successfully form new tumors.

Researchers Identify Targets to Inhibit the Spread of Melanoma

New Biomarker May Detect Stomach Cancer Early with a Blood Test

A newly discovered biomarker, the microRNA MiR130b, may help with early detection of stomach cancer and potentially improve treatment outcomes. MiR130b is produced by immune cells associated with the bacteria Helicobacter pylori (H. pylori), which can correlate with early, preneoplastic changes that can lead to the development of gastric cancer. Stomach cancer diagnosis currently requires endoscopic collection of stomach tissue, while the new biomarker can be detected through a simple blood test.

New Biomarker May Detect Stomach Cancer Early with a Blood Test